Cryo-Cell International(CCEL) - 2022 Q4 - Annual Report

On February 17, 2023, subsequent to the balance sheet date, the Company entered into a Second Amendment to the License Agreement (the "Second Amendment") with Duke. The Second Amendment changes the license fee due to Duke. The final $2,000,000 payment that was due on February 23, 2023 was removed and the license fee is paid in full. The Second Amendment added a new milestone payment of$1,000,000 upon FDA approval of the first licensed product comprising cord tissue derived MSC ("ctMSC") for autism spectrum ...